151 related articles for article (PubMed ID: 18426355)
1. Is vasopressin increasing or decreasing mortality in patients with septic shock?
Rehberg S; Ertmer C; Van Aken H; Westphal M
Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
[No Abstract] [Full Text] [Related]
2. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
3. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
Sandifer JP; Jones AE
Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
[No Abstract] [Full Text] [Related]
4. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
5. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
Anantasit N; Boyd JH; Walley KR; Russell JA
Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin in septic shock.
Russell JA
Crit Care Med; 2007 Sep; 35(9 Suppl):S609-15. PubMed ID: 17713417
[No Abstract] [Full Text] [Related]
7. Sepsis and pharmacogenomics: can the VAS(S)T majority of vasopressor treatment be individualized?*.
Westphal M; van Haren FM
Crit Care Med; 2014 Aug; 42(8):1944-5. PubMed ID: 25029134
[No Abstract] [Full Text] [Related]
8. Vasopressin in septic shock.
Landry DW; Oliver JA
N Engl J Med; 2008 Jun; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443
[No Abstract] [Full Text] [Related]
9. Vasopressin in septic shock: clinical equipoise mandates a time for restraint.
Russell JA
Crit Care Med; 2003 Nov; 31(11):2707-9. PubMed ID: 14605551
[No Abstract] [Full Text] [Related]
10. Septic shock--vasopressin, norepinephrine, and urgency.
Parrillo JE
N Engl J Med; 2008 Feb; 358(9):954-6. PubMed ID: 18305271
[No Abstract] [Full Text] [Related]
11. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
12. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
13. Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock?
Roumpf SK; Hunter BR
Ann Emerg Med; 2019 Jul; 74(1):153-155. PubMed ID: 30446352
[No Abstract] [Full Text] [Related]
14. Vasopressin: A tool as rescue therapy? Take care of dosages and adverse effects!
Angstwurm M
Crit Care Med; 2005 Nov; 33(11):2713-4. PubMed ID: 16276218
[No Abstract] [Full Text] [Related]
15. Vasopressin for vasopressor-dependent septic shock.
Szumita PM; Enfanto CM; Greenwood B; Wechsler ME
Am J Health Syst Pharm; 2005 Sep; 62(18):1931-6. PubMed ID: 16141113
[No Abstract] [Full Text] [Related]
16. Vasopressin in septic shock.
Dünser MW; Hasibeder WR; Wenzel V
N Engl J Med; 2008 Jun; 358(25):2736; author reply 2737-8. PubMed ID: 18572442
[No Abstract] [Full Text] [Related]
17. Corticosteroids and the original vasopressin and septic shock trial subgroups.
Southard RE; Boyle WA
Crit Care Med; 2010 Jan; 38(1):338; authore reply 338-9. PubMed ID: 20023496
[No Abstract] [Full Text] [Related]
18. Peripheral administration of vasopressin for catecholamine-resistant hypotension complicated by skin necrosis.
Bunker N; Higgins D
Crit Care Med; 2006 Mar; 34(3):935; author reply 935-6. PubMed ID: 16505698
[No Abstract] [Full Text] [Related]
19. [Vasopressin for treatment of hemodynamic disorders].
Adukauskiene D; Sirvinskas E; Kevelaitis E
Medicina (Kaunas); 2008; 44(2):167-73. PubMed ID: 18344670
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
Nguyen HB; Lu S; Possagnoli I; Stokes P
J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
